16Jun
Diligence Clauses and the Management of Uncertainty in Life Sciences Agreements
In times of uncertainty and disruption, setting expectations for performance with business partners and contractual counterparties can be more complicated than ever. Companies that develop drugs, biologics and medical devices have considerable...
By:
Skadden, Arps, Slate, Meagher & Flom LLP
Related
On May 31, the Federal Trade Commission (“FTC”) posted the agenda for its final hearing in the “C...
Read More >
If you are left in the dark about something, you don’t have the information you should have to make...
Read More >
STATE DEPARTMENT ISSUES FINAL RULE ORDERING DENIALS OF B VISAS TO COMBAT 'BIRTH TOURISM' The final ...
Read More >
Company Fired Employee After Seizure, Federal Agency Charged - DENVER - Gollnick Construction, Inc...
Read More >
There are big changes coming to what is required for motorcycle insurance in Michigan under the new ...
Read More >
During the Obama administration, the National Labor Relations Board (NLRB) rocked the HR world for e...
Read More >